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Available online 17 August 2015It has been very difﬁcult, if not impossible, to establishmouse induced pluripotent stem cells (iPSCs) from differ-
entiated cells, such as ﬁbroblasts, without leukemia inhibitory factor (LIF). We have established and maintained
LIF-independent iPSCs for longer than 120 days with modiﬁed Oct4 along with Sox2, Klf4, and c-Myc. The iPSCs
will provide a novel tool to investigate the roles of the LIF-Stat3 signaling pathway in mouse pluripotent stem
cells.
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Reprogramming factors: M3O (the ﬁrst 186 nucleotides of MyoD
were fused to the amino terminus of full-length Oct4), Sox2, Klf4, and
c-Myc were used.
Vector system: M3O was transduced with the TetO-FUW inducible
lentivirus vector; Sox2, Klf4, and c-Myc (SKM) were transduced with
the pMXs-IP retrovirus vector.Cell Biology and Development,
f Cardiac Surgery, University of
. This is an open access article underEvidence for the silencing of the reprogramming factors in iPS cells:
Transduced SKM were silenced as shown by RT-PCR (Fig. 1A). Expres-
sion of M3O was maintained by doxycycline during establishment and
maintenance of M3O-lenti-iPSCs-LIF(−).
Expression of pluripotencymarkers: Expression of endogenous Oct4
and Sox2was veriﬁedwith quantitative RT-PCR (qRT-CPR) (Fig. 1B). Ex-
pression of Nanog, SSEA-1, and alkaline phosphatase was conﬁrmed
with cell staining (Fig. 1C).
Capacity to differentiate into three germ layers: Teratomas contain-
ing tissues derived from three germ layers were formed after injection
into immunocompromised mice (Fig. 1D).
2. Materials and methods
M3O is a fusion gene between full-lengthOct4 and the transactivation
domain of mouse MyoD (Hirai et al., 2011). M3O with the FLAG se-
quence DYKDDDDK at their carboxyl terminus was cloned into the
TetO-FUW inducible lentivirus vector (Addgene, modiﬁed #20726).
Lentivirus encoding M3O was prepared by transfecting TetO-FUW-
M3O, psPAX2 (Addgene #12260), and pCMV-VSV-G (Addgene #8454)
into 293T cells with Lipofectamine 2000 (Life Technologies). Lentivirus
encoding FUW-M2rtTA (Addgene, #20342) (Hockemeyer et al., 2008)
was prepared in the same way. Polycistronic Sox2, Klf4, and c-Myc
(SKM) were inserted into the pMXs-IP retroviral vector (Kitamura
et al., 2003) and transfected into Plat-E cells (Morita et al., 2000) to pre-
pare the retrovirus. M3O-lentivirus and SKM-retrovirus were trans-
duced with 10 μg/ml polybrene into mouse embryonic ﬁbroblasts
(MEFs) harboring the Oct4-GFP transgene (B6;129S4-Pou5f1tm2Jae/J;
Jackson Laboratory, stock #008214) (Lengner et al., 2007). Transduced
MEFswere subcultured onto irradiatedMEF feeder cells in iPSCmedium
(DMEM, 20% FBS, 100 μM MEM non-essential amino acids, 100 μM
2-mercaptoethanol, 2 mM L-glutamine, and 2 μg/ml doxycycline) onthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of mouse M3O-lenti-iPSCs-LIF(−). (A) RT-PCR of the Klf4 transgene (Exo–Klf4) comparing MEFs transduced with SKM (positive control), O-retro-iPSCs-LIF(+)
(negative control), M3O-lenti-iPSCs-LIF(−), and MEFs (negative control). GAPDH was used as a loading control. (B) Relative expression levels of endogenous Oct4 and Sox2. The values
obtained with O-retro-iPSCs-LIF(+) were deﬁned as 1.0 for each gene. Average + SD of three independent experiments are shown. (C) Immunoﬂuorescence staining and alkaline phos-
phatase staining of M3O-lenti-iPSCs-LIF(−) cultured without LIF for 120 days. GFP was immunostained due to quenching of the signal during ﬁxation. Bar, 100 μm. (D) Hematoxylin and
eosin staining of teratoma sections obtained with M3O-lenti-iPSCs-LIF(−). Bar, 100 μm. (E) Karyotype analysis of M3O-lenti-iPSCs-LIF(−).
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maintained on feeder cells without LIF for longer than 120 days.
O-retro-iPSCs-LIF(+) were prepared from MEFs with retroviral OSKM
in the presence of LIF and used as a control in Fig. 1A and B.3. Immunoﬂuorescence and alkaline phosphatase staining
iPSCs were ﬁxed with 4% formaldehyde in PBS and stained with
antibodies against GFP (Santa Cruz Biotechnology, sc-8334), Nanog
(R&D Systems, AF2729), and SSEA-1 (Alexa Fluor 555-labeled, BD
Biosciences, 560119). Secondary antibodies included Alexa Fluor 488-
labeled anti-rabbit IgG (Life Technologies, A11304) and Cy3-labeled
anti-goat IgG (Jackson ImmunoResearch, 805-165-180). DNAwas coun-
ter stained with Hoechst 33342. Fluorescence images were captured
with an AxioCam camera attached to an Axiovert 200 M microscope
(Zeiss). Alkaline phosphatase was detected with a Millipore kit
(SCR004).4. RT-PCR
Total RNAwas preparedwith RNeasyMicro Kit (QIAGEN) and cDNA
was synthesized using SuperScript III reverse transcriptase (Life Tech-
nologies). Following primers were used for PCR. Exogenous Klf4:
5′-GGGAAGTCTTCTAACATGCG-3′ and 5′-GAAGGACGGGAGCAGAG-3′.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 5′-TGCACCAC
CAACTGCTTAG-3′ and 5′-GATGCAGGGATGATGTTC-3′.
5. Quantitative RT-PCR (qRT-PCR)
cDNA prepared from total RNA of M3O-lenti-iPSCs-LIF(−) was ap-
plied for qPCR with a GoTaq qPCR Master Mix (Promega) using the fol-
lowing primers. Endogenous Oct4: 5′-TCTTTCCACCAGGCCCCCGGCTC-3′
and 5′- TGCGGGCGGACATGGGGAGATCC-3′. Endogenous Sox2:
5′- AAAGGAGAGAAGTTTGGAGCCCGA-3′ and 5′-GGGCGAAGTGCAAT
TGGGATGAAA-3′. GAPDH was used for the normalization of the levels
of mRNA.
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Two-month-old NOD/SCID mice (Charles River) were intramuscu-
larly injectedwith 1 × 106M3O-lenti-iPSCs-LIF(−). Fourweeks after in-
jection, teratomas were ﬁxed with 10% formalin and embedded in
parafﬁn. Sections of 5-μm thickness were stained with hematoxylin
and eosin solution.
7. Karyotyping
Cells were arrested with colcemid, harvested, treated with 75 mM
KCl hypotonic solution, and ﬁxed with methanol and acetic acid at 3:1.
The cells were spread onto glass slides and stained with Wright-
Giemsa stain. G-banded metaphases were imaged and karyotyped
using Applied Spectral Imaging (ASI) software.
8. Veriﬁcation and authentication
Normal karyotype of 40, XY (Fig. 1E).
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